Navigation Links
Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
Date:9/21/2007

abine 1,250mg/m(squared), given by 30 minute intravenous infusion, on days 1 and 8 of each 21 day cycle.

The four week schedule used gemcitabine 1,000mg/m(squared), given by 30 minute intravenous infusion, on days 1, 8, and 15 of each 28 day cycle.

Cisplatin has been used at doses between 75-100mg/m(squared) once every 3 or 4 weeks.

Non-Small Cell Lung Cancer - Single-Agent Use

The recommended dose of gemcitabine is 1,000mg/m(squared), given by 30 minute intravenous infusion. This dose should be repeated once weekly for three weeks, followed by a one week rest period. This four week cycle is then repeated.

Pancreatic Cancer

The recommended dose of gemcitabine is 1,000mg/m(squared), given by 30 minute intravenous infusion. This dose should be repeated once weekly for up to 7 weeks, followed by a week of rest. Subsequent cycles consist of once weekly injections for 3 consecutive weeks out of every 4 weeks.

Bladder Cancer - Combination Use

The recommended dose for gemcitabine is 1,000mg/m(squared), given by 30 minute infusion. The dose should be given on days 1, 8, and 15 of each 28 day cycle in combination with cisplatin. Cisplatin is given at a recommended dose of 70mg/m(squared) on day 1 following gemcitabine or day 2 of each 28 day cycle. This four week cycle is then repeated.

Breast Cancer - Combination Use

The recommended regime is paclitaxel (175mg/m(squared)) on day 1 over 3 hours as an IV infusion, followed by gemcitabine (1,250mg/m(squared)) as a 30- 60 minute infusion on days 1 and 8 of each 21 day cycle. Patients should have an absolute granulocyte count of at least 1,500 (x 106/l) prior to initiation of the combination.

Gemcitabine can be administered on an outpatient basis.

Dosage reduction is based upon the amount of toxicity experienced by the patient. Patients receiving gemcitabine should be monitored prior to each dose for platelet, leucocyte, and granulocyte counts and, if necess
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment
2. Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007
3. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
4. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
5. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
6. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Malvern initiates European user group meetings for chemical imaging
9. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
10. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
11. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... LOS ANGELES , Aug. 29, 2014 /PRNewswire/ ... providing both financing alternatives and turnkey support services ... to announce that FINRA processed and approved the ... August 29, 2014, CannaMed Corporation will be known ... name change was accomplished through a merger with ...
(Date:8/29/2014)... , Aug. 29, 2014 The Competitive Intelligence ... and marketplace changes. CI leaders who adjust will succeed, ... In a new Best Practices, LLC study CI leaders ... insights, including: - Use secondary research whenever ... research - Internal staff who are creative ...
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP ... S.A. ("EDAP" or the "Company") (NASDAQ: EDAP ) ... in United States District Court, Southern District of ... is on behalf of a class consisting of all ... 1, 2013 and July 30, 2014, inclusive (the "Class ...
Breaking Medicine Technology:CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3
... 23, 2011 SCOLR Pharma, Inc. (OTCQB: SCLR) today ... orders for its extended-release nutritional products based on the ... represent SCOLR,s first significant direct retail sales of its ... President and CEO, said, "Shipment of these initial orders ...
... SHENZHEN, China, Dec. 23, 2011 /PRNewswire-Asia/ -- Winner Medical ... or the "Company"), a leading China-based exporter and retailer ... 100% cotton, today announced that BDO China Shu Lun ... appointed as the Company,s independent registered public accounting firm ...
Cached Medicine Technology:SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products 2Winner Medical Appoints BDO China as Independent Auditor 2
(Date:8/30/2014)... 30, 2014 "My wife suffered neck, ... car accident," said one of two inventors from Bethel, ... her shoulder and neck area. She tried other pillows ... and pressure, assisting in comfort and providing extra sleep." ... CRADLE to support the head, neck and back comfortably. ...
(Date:8/30/2014)... 30, 2014 Market Research Report ... is a professional and in-depth market survey on ... firstly reviews the basic information of Lab Oven ... report then explores global and China’s top manufacturers ... production value, and market share etc. , The ...
(Date:8/30/2014)... Serving contented clients since inception, #1 ... Outsourcing is now offering discount for Labor Day ... emphasize on putting forward the best of web development ... dedicated team of professionals and web developers and designers ... even the critical issues of web development and can ...
(Date:8/30/2014)... August 30, 2014 The federal ... lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston Scientific ... four cases selected for one of the proceeding’s ... August 18, 2014, U.S. District Judge Joseph R. ... disagrees with Boston Scientific’s contention that a consolidated ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: Transvenous lead extraction ... cases according to data from the European Lead Extraction ... at ESC Congress 2014 by Dr Maria Grazia Bongiorni, ... said: "The number of cardiac implantable electronic devices (CIED) ... in technology the number of complications has increased and ...
Breaking Medicine News(10 mins):Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3
... Oscient,Pharmaceuticals Corporation (Nasdaq: OSCI ) will ... year ended December 31, 2007 on,Wednesday, February 6, ... financial,markets. A conference call will be held at ... CEO, and other members of Oscient,s,management team. The ...
... in the,medical device industry, has passed the 500 million ... of this significant,milestone, the company will hold a brief ... Medical of St. Louis, Mo., the distributor who purchased,the ... to share in this significant achievement and,to know how ...
... Feb. 1 The globally active precious,metal and ... by purchasing the Interventional Business of Synovis Life,Technologies, ... was,closed on January 31, 2008. With this acquisition, ... people at 5 facilities in the,U.S., Germany, Switzerland ...
... bout of non-REM sleep (45 minutes) obtained during a daytime ... a study published in the February 1 issue of the ... PhD, of the Center for Sleep and Cognition and the ... subjects (11 males, 22 females) with an average age of ...
... new and increasingly popular type of minimally invasive sinus ... radiation during the procedure, a level considered to be ... February 2008 issue of the journal Otolaryngology Head ... cases of balloon catheter sinus ostial dilation fluoroscopy performed ...
... more beverages a day increased chances by 85%, study finds ... drinks and fructose is strongly associated with increased risk of gout ... uric acid in the blood, is a joint disease that causes ... in men, have doubled in the United States over the past ...
Cached Medicine News:Health News:Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results 2Health News:MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical 2Health News:Heraeus Strengthens Medical Components Business 2Health News:Journal Sleep: Study concludes a daytime nap can benefit a person's memory performance 2Health News:Sugary Soft Drinks Boost Gout Risk in Men 2
... microplate washers available to handle ... cell-based assays. Embla 384 Cell ... have been optimized to avoid ... robotic compatible and have been ...
... The Labcyte miniGene LW is a new plate ... to 96 and 384 channel microplates with flat, ... equipped with 8 or 16 channel nozzle heads. ... a breeze. An optional plate stacker is available ...
Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
... to 8000 L/day of Type III Laboratory-grade ... to produce up to 8000 L/day of ... feedwater., One Complete Purification and Control Unit, ... centralized system, providing total control of all ...
Medicine Products: